|
KRCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.449600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.647800E-02 |
| Normal-vs-Stage2 |
2.253400E-01 |
| Normal-vs-Stage3 |
3.942100E-02 |
| Normal-vs-Stage4 |
1.614590E-01 |
| Stage1-vs-Stage2 |
9.376400E-01 |
| Stage1-vs-Stage3 |
5.638200E-01 |
| Stage1-vs-Stage4 |
9.624200E-01 |
| Stage2-vs-Stage3 |
6.140400E-01 |
| Stage2-vs-Stage4 |
9.221000E-01 |
| Stage3-vs-Stage4 |
7.451200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.544100E-02 |
| Normal-vs-AfricanAmerican |
5.756300E-02 |
| Normal-vs-Asian |
4.155600E-01 |
| Caucasian-vs-AfricanAmerican |
8.270400E-01 |
| Caucasian-vs-Asian |
9.120600E-01 |
| AfricanAmerican-vs-Asian |
8.589400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.417700E-02 |
| Normal-vs-Female |
2.853900E-02 |
| Male-vs-Female |
5.399400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.223700E-02 |
| Normal-vs-Extreme_Weight |
4.690300E-02 |
| Normal-vs-Obese |
4.849500E-02 |
| Normal-vs-Extreme_Obese |
3.200200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.637200E-01 |
| Normal_Weight-vs-Obese |
6.507400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.292200E-01 |
| Extreme_Weight-vs-Obese |
9.908200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.835200E-01 |
| Obese-vs-Extreme_Obese |
9.767200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.564200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.546800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.703400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.243400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.591200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.138400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.562600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.182100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.457200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.882600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.297400E-01 |
| Normal-VS-Type2 PRCC |
7.81770000000126E-05 |
| Normal-VS-KIRP CIMP |
6.858400E-02 |
| Normal-VS-Unclassified PRCC |
3.774500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.27429999999362E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.388000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.815700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.734000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.537600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.914600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.551230E-04 |
| Normal-vs-N1 |
4.360800E-01 |
| Normal-vs-N2 |
8.373700E-02 |
| N0-vs-N1 |
4.714000E-02 |
| N0-vs-N2 |
8.396400E-01 |
| N1-vs-N2 |
4.854000E-01 |
|
|
